JB Capital Partners LP raised its position in RadNet, Inc. (NASDAQ:RDNT - Free Report) by 15.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,504,061 shares of the medical research company's stock after buying an additional 206,850 shares during the quarter. RadNet comprises about 20.0% of JB Capital Partners LP's portfolio, making the stock its largest position. JB Capital Partners LP owned about 2.03% of RadNet worth $104,367,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in RadNet by 8.1% in the first quarter. Vanguard Group Inc. now owns 4,600,539 shares of the medical research company's stock valued at $223,862,000 after acquiring an additional 345,822 shares during the last quarter. O Shaughnessy Asset Management LLC acquired a new position in shares of RadNet during the 1st quarter worth $274,000. Price T Rowe Associates Inc. MD raised its holdings in shares of RadNet by 6.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 35,054 shares of the medical research company's stock worth $1,706,000 after buying an additional 2,222 shares in the last quarter. Janus Henderson Group PLC boosted its stake in RadNet by 108.6% in the first quarter. Janus Henderson Group PLC now owns 64,029 shares of the medical research company's stock valued at $3,112,000 after buying an additional 33,335 shares in the last quarter. Finally, GAMMA Investing LLC grew its position in RadNet by 74.7% in the second quarter. GAMMA Investing LLC now owns 865 shares of the medical research company's stock valued at $51,000 after acquiring an additional 370 shares during the last quarter. 77.90% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
RDNT has been the subject of a number of research reports. Truist Financial increased their target price on shares of RadNet from $80.00 to $94.00 and gave the stock a "buy" rating in a report on Friday. Sidoti raised shares of RadNet to a "strong-buy" rating in a research note on Friday, October 4th. Barclays raised shares of RadNet from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $57.00 to $79.00 in a research note on Friday, September 6th. Finally, Jefferies Financial Group increased their price target on RadNet from $75.00 to $80.00 and gave the company a "buy" rating in a research note on Thursday, September 19th. One investment analyst has rated the stock with a sell rating, four have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $78.25.
Check Out Our Latest Report on RadNet
Insider Buying and Selling
In other RadNet news, EVP David Jeffrey Katz sold 12,300 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $81.65, for a total transaction of $1,004,295.00. Following the completion of the sale, the executive vice president now owns 62,909 shares of the company's stock, valued at approximately $5,136,519.85. This represents a 16.35 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Ranjan Jayanathan sold 38,557 shares of the company's stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $80.00, for a total transaction of $3,084,560.00. Following the completion of the sale, the insider now directly owns 192,724 shares in the company, valued at approximately $15,417,920. This represents a 16.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.12% of the stock is currently owned by insiders.
RadNet Trading Down 0.9 %
NASDAQ RDNT traded down $0.73 on Friday, hitting $81.76. The company's stock had a trading volume of 425,097 shares, compared to its average volume of 551,174. The company's 50-day moving average is $72.43 and its 200 day moving average is $65.02. The firm has a market cap of $6.05 billion, a PE ratio of -1,168.00 and a beta of 1.75. RadNet, Inc. has a 1-year low of $32.37 and a 1-year high of $93.65. The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.89.
RadNet Company Profile
(
Free Report)
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
Featured Articles
Before you consider RadNet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RadNet wasn't on the list.
While RadNet currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.